Skip to main content

Table 3 Parameters of lipid-transport function in the blood in patients with myocardial infarction on the 1st and 12th days of development of the disease

From: Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction

Variables Control, n = 33 Group 1, ≥ 75% stenosis of a coronary artery, n = 135 Group 2, ≥ 75% stenosis 2 coronary, n = 115 Group 3, ≥ 75% stenosis of 3 or more coronary arteries, n = 150
1-th day 12-th day 1-th day 12-th day 1-th day 12-th day
TC, mmol/ 4.30 5.91 5.80 5.68 5.66 5.83 5.59
(3.65;5.50) (5.56;6.65)a (5.65;6.01) (5.57;5,80)a (5.42;5.87) (5.74;5.99)a (5.50;5.72)
TG, mmol/L 1.13 1.83 2.75 2.16 2.23 1.91 2.10
(0.78;1.23) (1.56;2.7)a (2.52;3.1)b (2.10;2.24)a (2.14;2.37) (1.82;2.02)a (2.01;2.29)
HDL-C, mmol/L 1.31 1.12 1.01 0.95 1.19 0.98 0.96
(1.02;1.72) (0.96;1.25)a (0.95;1.110) (0.89;1,05)ac (1.09;1.31) (0.86;1,10)ac (0.89;1.1)
LDL-C, mmol/L 2.03 2.73 3.30 2.32 3.36 2.96 3.38
(1.51;2.55) (2.59;2,99) (3.23;3.41)b (2.25;2.48)a (3.27;356)b (2.84;3.15)a (3.27;3.57)b
VLDL-C, mmol/L 0.44 0.82 1.24 0.98 1.01 0.87 0.96
(0.33;0.53) (0.64;0.98)a (1.15;1,36)b (0.87:1.12)a (0,96;1,15) (0.78;0,97)a (0,86;1.03)
Apo B, g/L 1.02 1.26 1.43 1.31 1.87 1.36 1.46
(0.76;1.25) (1.19;1.43)a 1.33;1,52)b (1.23;1.1.43)a (1,79;2,01)b (1.26;1.45)a (1.31;1.59)
Apo A1, g/L 1.43 1.30 1.56 1.25 1.65 1.24 1.33
(1.29;1.73) (1,21;1,42) (1.50;1.68) (1.19;1.32)a (1.58;1,78) (1.19;1,31)a (1,29;1.49)
Аpо-В/Apо-А1 0.71 0.98 0.97 1.07 1.08 1.62 1.22
(0.59;1.01) (0.89;1.12)a (0.88;1.11) (1.01;1.19)a (1.01;119) (1,45;1,79)a (1.12;1.35)
Atherogenic index 2.28 4.28 4.71 4.97 3.75 4.95 4,82
(2.20;2.36) (4.18;4,32)a (4.62;4.76) (4.85;5.10)a (3.62;3,87) (4.82;5,15)a (4.69;4.96)
FFA, mmol/L 0.20 1.48 0.64 1.89 0.68 2.00 0.84
(0.10;1.10) (1.40;1.162)a (0.58;0.69)b (1.81;1.99)ac (0.59;0.79)b (1.91;2.15)ac (0.78;0,98)bc
  1. Abbreviations: TC. total cholesterol; TG. Triglycerides; HDL-C.cholesterol high-density lipoproteins; LDL-C. cholesterol low-density lipoproteins; VLDL-C. cholesterol very-low-density lipoproteins; Apo B. apolipoprotein B; Apo A1. apolipoprotein A.
  2. Note: a - significant differences in the parameters with the control group, (p ≤ 0.05).
  3. b - significant difference parameters on day 1 and 12, (p ≤ 0.05).
  4. c - significant difference between 1 and 2, groups 1 and 3, (p ≤ 0.05).